Kanvas Labs also just launched its flagship application on Android. According to founder and CEO Vic Singh the main Kanvas app today has over 500,000 users and is growing at 100,000 users per month.

On Monday, Kanvas announced it has a $12.5 million seed round, co-led by DCVC and Lions Capital, bringing its total investments to $29.5 million. The company declined to share a valuation.

About Kanvas Biosciences Kanvas Biosciences is a therapeutics company building the world’s first microbiome drug screening, discovery and manufacturing platform to accelerate the development of ...

As Federation Bio fades away, Kanvas Biosciences has snapped up two of the biotech’s assets as well as its microbial library and the company’s chief scientific officer Lee Swem, Ph.D., to lead ...

Kanvas Bio plans to request a pre-Investigational New Drug meeting with the FDA for KAN-001 in January 2025, with the goal of beginning a clinical trial for the drug as soon as possible.